United States securities and exchange commission logo

                     July 24, 2023

       Yi Larson
       Chief Financial Officer
       103 Carnegie Center Drive, Suite 309
       Princeton, NJ 08540

                                                        Re: LianBio
                                                            Form 10-K for
Fiscal Year Ended December 31, 2022
                                                            Filed March 28,
                                                            File No. 001-40947

       Dear Yi Larson:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.


                     Division of Corporation Finance

                     Office of Life Sciences